CAS: 708275-58-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | JNJ-10397049 REF: TM-T22880CAS: 708275-58-5 | - - - | 49.00 €~93.00 € | Mon 16 Dec 24 |
 | JNJ 10397049 REF: TR-J211330CAS: 708275-58-5 | - - - | 17,795.00 € | Tue 21 Jan 25 |
 | JNJ 10397049 REF: 3D-IDB27558CAS: 708275-58-5 | Min. 95% | 149.00 €~1,567.00 € | Wed 05 Feb 25 |
JNJ-10397049
CAS:708275-58-5
OX2 receptor antagonist
Formula:
C19H20Br2N2O3
Color and Shape:
Solid
Molecular weight:
484.18
Ref: TM-T22880
| 2mg | 93.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
JNJ 10397049
Controlled ProductCAS:708275-58-5
Formula:
C19H20Br2N2O3
Color and Shape:
Neat
Molecular weight:
484.182
Ref: TR-J211330
| 100mg | 17,795.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
JNJ 10397049
CAS:708275-58-5
JNJ 10397049 is an experimental drug that has been shown to have antinociceptive properties in …
Formula:
C19H20Br2N2O3
Purity:
Min. 95%
Molecular weight:
484.18 g/mol
Ref: 3D-IDB27558
| 1mg | 149.00 € | ||
| 5mg | 409.00 € | ||
| 10mg | 583.00 € | ||
| 25mg | 1,041.00 € | ||
| 50mg | 1,567.00 € |
Estimated delivery in United States, on Wednesday 5 Feb 2025
